Arora H, Jensen M, Yuan Y, Wo A, Vogt S, Paunesku T et al (2012) Nanocarriers enhance doxorubicin uptake in drug-resistant ovarian cancer cells. Cancer Res 72(3):769–778PubMedCentralPubMed

Astsaturov I, Cohen R, Harari P (2007) EGRF-targeting monocolonal antibodies in head and neck cancer. Curr Cancer Drug Targets 7:650–665PubMed

Balogh L (2010) Why do we have so many definitions for nanoscience and nanotechnology? Nanomed Nanotechnol Biol Med 6:397–398

Balogh L, Nigavekar S, Nair B, Lesniak W, Zhang C, Sung L (2007) Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomed Nanotechnol Biol Med 3:281–296

Bedi D, Musacchio T, Fagbohun O, Gillespie J, Deinnocentes P, Brid C et al (2011) Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomed Nanotechnol Biol Med 7(315):323

Bhatt R, de Vries P, Tulinsky J (2003) Synthesis and in vivo antitumor activity of poly(L-glutamic acid) conjugaes of 20S-camptothecin. J Med Chem 46:190–193PubMed

Bhattacharyya S, Kudgus R, Bhattachrya R, Mukherjee P (2011) Inorganic nanoparticles in cancer therapy. Pharm Res 28:237–259PubMedCentralPubMed

Bhirde A, Xie J, Swierczewska M, Chen M (2011) Nanoparticles for cell labeling. Nanoscale 3(142):153

Bickford L, Agollah G, Drezek R, Yu T (2008) Evaluation of immunotargeted gold nanoshells as rapid diagnostic imaging agents for HER2-overexpressing breast cancer cells: a time-based analysis. Nanobiotechnology 4:1–8

Bickford L, Agollah G, Drezek R, Yu T (2010) Silica-gold nanoshells as potential intraoperative molecular probes for HER2-overexpression in ex vivo breast tissue using near-infrared confocal microscopy. Breast Cancer Res Treat 120:547–555PubMed

Bouclier C, Marsaud V, Bawa O, Nicolas V, Moine L (2010) Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor α and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts. Breast Cancer Res Treat 122:145–158PubMed

Cho B, Hurkman C, Damen E (2002) Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol 62:127–136PubMed

Cho K, Wang X, Nie S (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310–1316PubMed

Conde J, Doria G, Baptista P (2011) Noble metal nanoparticles applications in cancer. J Drug Deliv 2012: in press

de Lopes Menezes D, Mayer L (2002) Pharmacokinetics of Bcl-2 antisense oligonuclieotide (GS3139) combined with doxorubicin in scid mice bearing human breast cancer solid tumor xenografts. Cancer Chemother Pharmacol 49:57–68

DeNardo S, DeNardo G, Miers L, Natarajan A, Foreman A (2011) Development of tumor targeting bioprobes (111-In chimeric l6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res 11:7087s–7092s

Dickler A, Kirk M, Seif N (2007) A dosimetric comparison of mammosite high-dose-rate brachytherapy and xoft axxent electronic brachytherapy. Brachytherapy 6(2):164–168PubMed

Dooley W, Wurzer J, Megahy M, Schreiber G, Roy T, Prouix G (2011) Electronic brachytherapy as adjuvant therapy for early stage breast cancer: a retrospective analysis. OncoTargets Ther 4:13–20

Eifel P, Axelson J, Costa J, Crowley J, Curran W (2000) National institutes of health consensus development conference statement: adjuvant therapy for breast cancer. J Nat Cancer Inst 93(13):979–989

El-Sayed M, Kiani M, Naimark M, Hikal A, Ghandehari H (2001) Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium. Pharm Res 18:23–28PubMed

Farokhzad O, Chenng J, Telpy B, Sherifi I, Jon S, Kantoff P et al (2006) Targeted Nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Nat Acad Sci 103(16):16315–16320

Fisher B, Anderson S, Bryant J (2002a) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMed

Fisher B, Bryant J, Dignam J (2002b) Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20(20):4141–4149PubMed

Fyles A, McCready D, Manchul L (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early stage breast cancer. N Engl J Med 351:963–970PubMed

Gradishar W, Tjulandin S, Davidson N (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23:7794–7803PubMed

Green J, Chiu E, Leschiner E, Langer R, Anderson D (2007) Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells. Nano Lett 7:874–879PubMed

Gruttner C, Muller K, Westphal F, Foreman A, Ivkov R (2007) Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J Magn Magn Mater 311(1):181–186

Haffty B, Kim J, Yang Q, Higgins S (2006) Concurrent chemo-radiation in the conservative management of breast cancer. Int J Radiat Oncol Biol Phys 66(5):1306–1312PubMed

Hainfeld J, Slatkin D, Smilowitz H (2004) The use of gold nanoparticles to enhance radiotherarpy in mice. Phys Med Biol 49:309–315

Hallahan D, Mauceri H, Seung L, Dunphy E, Wayne J, Hanna N et al (1995) Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1(8):786–791PubMed

Hariri G, Yan H, Wang H, Han Z, Hallahan D (2010) Radiation-guided drug delivery to mouse models of lung cancer. Clin Cancer Res 16(20):4968–4977PubMedCentralPubMed

Hariri G, Wellons M, Morris W, Lukehart C, Hallahan D (2011) Multifunctional FePt nanoparticles for radiation-guided targeting and imaging of cancer. Ann Biomed Eng 39(3):946–952PubMedCentralPubMed

Harris E, Christensen V, Hwang W, Fox K, Solin L (2005) Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol 23(1):11–16PubMed

Herold D, Das I, Stobbe C, Iyer R, Chapman J (2000) Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol 76:1357–1364PubMed

Hoffman A (2008) The origins and evolution of “controlled” drug delivery systems. J Controlled Release 132:153–163

Hofheinz R, Gnad-Vogt S, Beyer U, Hochhaus A (2005) Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 16:691–707PubMed

Holli K, Hietanen P, Saaristo R, Huhtala H (2009) Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. J Clin Oncol 27(6):927–932PubMed

Horcajada P, Chalati T, Serre C, Gillet B, Sebrie C, Batti T et al (2010) Porous metal-organic-framework nanoscale carries as a potential platform for drug delivery and imaging. Nat Mater 9:172–178PubMed

Hughes K, Schnaper L, Berry D (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. NEJM 351:971–977PubMed

Jamison T, Bakhshi R, Petrova D, Pocock R, Imani M, Seifalian A (2007) Biological applications of quantum dots. Biomaterials 28:4717–4732

Janes K, Fresneau M, Marazuela A, Fabra A, Alonso M (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Controlled Release 73:255–267

Johannes L, Lamaze C (2002) Clathrin-dependent or not: is it still the question? Traffic 3(7):443–451PubMed